Medallion Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.2K Sell
258
-4,457
-95% -$522K 0.01% 517
2026
Q1
$567K Buy
4,715
+766
+19% +$88.4K 0.19% 115
2025
Q4
$416K Sell
3,949
-85
-2% -$7.98K 0.14% 146
2025
Q3
$339K Buy
4,034
+1
+0% +$82 0.12% 165
2025
Q2
$329K Buy
4,033
+1
+0% +$79 0.13% 164
2025
Q1
$352K Buy
4,032
+49
+1% +$4.58K 0.16% 138
2024
Q4
$394K Buy
+3,983
New +$411K 0.2% 111

Other funds holding MRK

Medallion Wealth Advisors's MRK Position: Q2 2026 in Review

Medallion Wealth Advisors reduced its Merck (MRK) stake by 95% in Q2 2026, selling an estimated $522K and leaving 258 shares worth $38.2K. The position accounts for 0.01% of the portfolio, ranked #517.

Medallion Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $567K in Q1 2026. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Medallion Wealth Advisors held 258 shares of Merck worth $38.2K as of Q2 2026.
  • Medallion Wealth Advisors sold 4,457 Merck shares in Q2 2026, an estimated $522K.
  • Merck made up 0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #517 holding.
  • Medallion Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Merck position peaked at $567K in Q1 2026.
  • 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.